These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4730296)

  • 1. Decrease of litter size and fetal monoamines by 6-hydroxydopamine in mice.
    Castrén O; Airaksinen M; Saarikoski S
    Experientia; 1973 May; 29(5):576-8. PubMed ID: 4730296
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical sympathectomy of the rabbit oviduct using 6-hydroxydopamine.
    Eddy CA; Black DL
    J Reprod Fertil; 1973 Apr; 33(1):1-9. PubMed ID: 4699444
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrastructural changes in cardiac muscle cells after administration of reserpine, parachlorophenylalanine, or 6-hydroxydopamine. The relationship of the changes to depletion of serotonin or norepinephrine.
    Hagopian M; Gershon MD; Nunez EA
    Lab Invest; 1973 Nov; 29(5):562-9. PubMed ID: 4270953
    [No Abstract]   [Full Text] [Related]  

  • 4. Norepinephrine and serotonin in the tissues and venoms of 2 pit vipers.
    Anton AH; Gennaro JF
    Nature; 1965 Dec; 208(5016):1174-5. PubMed ID: 5870315
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of reserpine, 6-hydroxydopamine, p-chlorophenylalanine and a combination of these substances on the grooming behaviour of mice.
    Rohte O; Müntzing J
    Psychopharmacologia; 1973 Aug; 31(4):333-42. PubMed ID: 4270202
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
    Teicher MH; Barber NI; Reichheld JH; Baldessarini RJ; Finklestein SP
    Brain Res; 1986 Nov; 395(1):124-8. PubMed ID: 2430678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of intracerebroventricular injection of 6-hydroxydopamine and 5,6-dyhydroxytryptamine on the phasic secretion of luteinizing hormone (author's transl)].
    Montilla P; Muñoz M; Palacios JL
    Rev Esp Fisiol; 1979 Jun; 35(2):163-8. PubMed ID: 482718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
    Quattrone A; Samanin R
    Eur J Pharmacol; 1977 Feb; 41(3):336-6. PubMed ID: 837975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
    Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté L; Cohen G
    J Neurochem; 1973 May; 20(5):1345-50. PubMed ID: 4716829
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of midbrain raphe lesion and of 6-hydroxydopamine on the antinociceptive action of buprenorphine in rats.
    Cowan A; Ghezzi D; Samanin R
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):302-5. PubMed ID: 4851667
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative measurements of placental transfer and distribution of radioactive atropine in fetus.
    Kivalo I; Saarikoski S
    Ann Chir Gynaecol Fenn; 1970; 59(2):80-4. PubMed ID: 5454251
    [No Abstract]   [Full Text] [Related]  

  • 16. The biochemical and pharmacological properties of 6-aminodopamine: similarity with 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté LJ; Cohen G
    J Neurochem; 1973 Jul; 21(1):111-6. PubMed ID: 4720889
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intensified aggressivity of dominant male mice after the intraventricular administration of 6-hydroxydopamine].
    Serova LI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(3):513-8. PubMed ID: 3142159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenaline contents of hypothalamus and adrenal gland increased by postnatal administration of 6-hydroxydopamine.
    Lew GM; Quay WB
    Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):807-12. PubMed ID: 5170594
    [No Abstract]   [Full Text] [Related]  

  • 19. Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol.
    Harbison RD; Mantilla-Plata B
    J Pharmacol Exp Ther; 1972 Feb; 180(2):446-53. PubMed ID: 5010682
    [No Abstract]   [Full Text] [Related]  

  • 20. 6-Hydroxydopamine: effect on mouse brain monoamines and 14C-noradrenaline uptake.
    Masuoka DT; Alcaraz AF
    Eur J Pharmacol; 1973 Nov; 24(2):234-42. PubMed ID: 4765746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.